NT PHARMA News

Tailing Pharmaceuticals (1011.HK): Successful transformation of innovative drugs has entered the harvest period

國元(香港)Mar 23, 2017 11:00

Tailing Pharmaceutical (1011.HK) Interim Report Commentary: Acquiring Novartis products to gradually enrich the orthopedic field's product line

光大證券Aug 24, 2016 11:00

Tai Ling Medicine (1011.HK): successful transformation will enter a period of rapid development

國元(香港)Aug 20, 2016 11:00

CHINA NT PHARMA GROUP (1011.HK): strong growth

申萬宏源研究Mar 28, 2016 11:00

CHINA NT PHARMA GROUP (1011:HK): performance foresight

申萬宏源研究Feb 23, 2016 10:00

Tai Ling Pharmaceutical (1011.HK) comments: great potential for the introduction of strategic investors in the health sector

光大證券Jan 4, 2016 10:00

In-depth study of 1011.HK: the reversal trend has obviously entered a period of rapid growth.

光大證券Dec 29, 2015 10:00

CHINA NT PHARMA GROUP (1011.HK): stock incentive landing

申萬宏源研究Sep 6, 2015 11:00

Tailing Pharmaceutical (1011.HK) in-depth report: on the right track

上海證券Jul 20, 2015 11:00

1011.HK Research Bulletin: pharmaceutical distributors looking forward to a reversal of predicament

國元(香港)Mar 4, 2014 10:00

Goldman Sachs Group was given a neutral rating of 01011-HK for the first time, seeing HK $3.20.

高盛Jun 8, 2011 03:55

Tailing Pharmaceutical (01011.HK) New share Review: vaccine Distributor and Promotion Service provider in China

光大控股Apr 10, 2011 11:00

Perspective on Tailing Pharmaceuticals (01011.HK) IPO

信達國際Apr 10, 2011 11:00